TORONTO, May 28, 2026 /CNW/ - Vimy Pharma announced that it filed its Abbreviated New Drug Submission (ANDS) with Health Canada earlier this month for a generic version of Ozempic® (semaglutide ...
Par Pharmaceutical Cos., Inc. today filed multiple Form 10-Q/As, amended quarterly reports, with the U.S. Securities and Exchange Commission.Par Pharmaceutical Cos., Inc. (NYSE: PRX) today filed ...
The company has proposed an IPO of 1.91 crore equity shares, comprising a fresh issue of 1.18 crore shares and an ...
India, June 24 -- Chemical products supplier Ujin Pharma has filed preliminary papers with capital markets regulator SEBI to ...
Purdue Pharma, the makers of the highly addictive painkiller OxyContin, filed for Chapter 11 bankruptcy Sunday as part of an agreement for settling a myriad of lawsuits it faces over the nation's ...
Innate Pharma S.A. is a global, clinical-stage biotechnology company developing immunotherapies for cancer patients. Its innovative approach aims to harness the innate immune system through ...
Purdue Pharma has filed a new bankruptcy plan that will distribute more than $7.4 billion to compensate opioid epidemic ...
(RTTNews) - PhaseBio Pharmaceuticals Inc. (PHAS) said Monday that it has elected to file a voluntary petition under Chapter 11 of the Bankruptcy Code in the U.S. Bankruptcy Court for the District of ...
New initiative from Silo Pharma designed to align with federal actions to accelerate mental health innovation using psychedelic medicines Silo Pharma targets unmet need in a drug market with no ...
Add Yahoo as a preferred source to see more of our stories on Google. FILE PHOTO: Bottles of prescription painkiller OxyContin made by Purdue Pharma LP sit on a shelf at a local pharmacy in Provo By ...
the annual financial report, the annual management report, the corporate governance report provided for under Article L. 225-37 of the French Commercial Code, the report of Statutory Auditors. Innate ...
SARASOTA, FLA., May 07, 2026 (GLOBE NEWSWIRE)-- Silo Pharma (Nasdaq: SILO) ("Silo” or "the Company”), a developmental-stage biopharmaceutical company focused on novel therapeutics and drug delivery ...